Panel Discussion/ Q&A: Plants as new sources of medicinals: Production of protein pharmaceuticals in food and non-food plants
Loading...
No Access Until
Permanent Link(s)
Other Titles
Author(s)
Abstract
Regulation of transgenic organisms should not be based on the process used to produce them but rather than on the host and the added trait. Highly activist and more moderate public-interest organizations and the regulatory system and associated costs have debilitated public-sector agricultural biotechnology. There is concern over the possibility of adulteration of food if PMPs are produced in crops such as corn, soy and canola. The Grocery Manufacturers of America has asked for a safety evaluation of the implications if PMP-producing food crops are commingled in the food supply; reasonable standards are needed.
Journal / Series
Volume & Issue
Description
Sponsorship
Date Issued
2005
Publisher
NABC
Keywords
Agricultural biotechnology; environment, human health; GMO, genetic engineering, pharming; plant based vaccines; medicinals; regulation; liability, patents; stewardship
Location
Effective Date
Expiration Date
Sector
Employer
Union
Union Local
NAICS
Number of Workers
Committee Chair
Committee Co-Chair
Committee Member
Degree Discipline
Degree Name
Degree Level
Related Version
Related DOI
Related To
Related Part
Based on Related Item
Has Other Format(s)
Part of Related Item
Related To
Related Publication(s)
Link(s) to Related Publication(s)
References
Link(s) to Reference(s)
Previously Published As
Government Document
ISBN
ISMN
ISSN
Other Identifiers
Rights
Attribution-NonCommercial-NoDerivatives 4.0 International
Types
book chapter